Rooney Terence
Transaction: 07/27/2026
OTHER
Change
0
Price
Not reported
Filing
07/27/2026
Type
OTHER
Kymera Therapeutics, Inc.
KYMR • Biotechnology
$108.07
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$10.61B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.05Healthy liquidity · 10.47Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 12, 2026, 12:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$108.07
Change0.00%
Shares Out98.18M
Market Cap$10.61B
Enterprise Value$10.00B
52W Range37.57 - 130.05
Beta1.96
P/E-35.41
P/S101.06
P/B7.03
P/FCF-44.59
EV/Sales95.23
Price$108.07
Change0.00%
Shares Out98.18M
Market Cap$10.61B
Enterprise Value$10.00B
52W Range37.57 - 130.05
Beta1.96
P/E-35.41
P/S101.06
P/B7.03
P/FCF-44.59
EV/Sales95.23
EV/EBITDA-32.54
EV/FCF-42.01
Earnings Yield-2.82%
FCF Yield-2.24%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-8.91%
Profit Margin-7.94%
Debt/Eq0.05
Current Ratio10.47
Quick Ratio10.47
Target$138.20
Target Upside27.88%
Target Median$139.00
Target Range97.00 - 180.00
Volume2.36M
Avg Volume719.61K
EPS Surprise0.18
Investment DNA
How strong this company looks for long-term investors
33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
44/100
Why this score▼
Manageable debt level · 0.05Healthy liquidity · 10.47Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 27 analyst votes · 2026-10-20
94/100
Bullish
Bullish
24
Hold
3
Bearish
0
Price Target
2026-08-12
Low
$97.00
Mean
$129.64
Median
$135.00
High
$155.00
Insider Transactions
Recent executive and insider activity
Rooney Terence
Transaction: 07/27/2026
BUY
Change
+38,000
Price
Not reported
Filing
07/27/2026
Type
BUY
Rooney Terence
Transaction: 07/27/2026
BUY
Change
+76,000
Price
$110.05
Filing
07/27/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Rooney Terence | OTHER | 0 | Not reported | 07/27/2026 | 07/27/2026 |
| Rooney Terence | BUY | +38,000 | Not reported | 07/27/2026 | 07/27/2026 |
| Rooney Terence | BUY | +76,000 | $110.05 | 07/27/2026 | 07/27/2026 |
| Mainolfi Nello | SELL | -4,441 | $2.08 | 07/07/2026 | 07/07/2026 |
| Mainolfi Nello | SELL | -50,000 | $119.00 | 07/07/2026 | 07/07/2026 |
| Mainolfi Nello | SELL | -80,000 | $2.08 | 07/01/2026 | 07/02/2026 |
| Mainolfi Nello | SELL | -3,336 | $116.56 | 07/01/2026 | 07/02/2026 |
| Goodman Noah | SELL | -3,389 | $114.29 | 07/01/2026 | 07/02/2026 |
| Jacobs Bruce N. | SELL | -61,378 | $5.33 | 06/30/2026 | 07/02/2026 |
| Jacobs Bruce N. | SELL | -3,200 | $117.70 | 06/30/2026 | 07/02/2026 |
| Booth Bruce | SELL | -130 | $111.20 | 06/29/2026 | 07/02/2026 |
| Booth Bruce | SELL | -3,024 | $107.76 | 06/29/2026 | 06/30/2026 |
| Booth Bruce | SELL | -1,729 | $118.66 | 06/26/2026 | 06/30/2026 |
| BVF PARTNERS L P/IL | SELL | -51,858 | $106.50 | 06/26/2026 | 06/26/2026 |
| Goodman Noah | SELL | -2,500 | $119.00 | 06/25/2026 | 06/25/2026 |
| Goodman Noah | SELL | -5,000 | $21.05 | 06/25/2026 | 06/25/2026 |
| Booth Bruce | SELL | -2,646 | $118.60 | 06/25/2026 | 06/25/2026 |
| BAKER BROS. ADVISORS LP | BUY | +6,068 | $99.87 | 06/24/2026 | 06/25/2026 |
| MARAGANORE JOHN | BUY | +6,068 | $99.87 | 06/24/2026 | 06/25/2026 |
| Esposito Pamela | BUY | +6,068 | $99.87 | 06/24/2026 | 06/25/2026 |